Capricor Therapeutics, Inc. (CAPR)
10.24
-0.98
(-8.73%)
USD |
NASDAQ |
Nov 12, 16:00
10.24
0.00 (0.00%)
Pre-Market: 08:00
Capricor Therapeutics Total Assets (Quarterly) : 330.37M for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 330.37M |
| June 30, 2026 | 368.74M |
| March 31, 2026 | 326.28M |
| December 31, 2025 | 359.95M |
| September 30, 2025 | 126.44M |
| June 30, 2025 | 133.57M |
| March 31, 2025 | 153.77M |
| December 31, 2024 | 172.27M |
| September 30, 2024 | 92.95M |
| June 30, 2024 | 38.28M |
| March 31, 2024 | 49.44M |
| December 31, 2023 | 58.73M |
| September 30, 2023 | 37.15M |
| June 30, 2023 | 46.01M |
| March 31, 2023 | 53.86M |
| December 31, 2022 | 50.09M |
| September 30, 2022 | 53.93M |
| June 30, 2022 | 58.07M |
| March 31, 2022 | 64.92M |
| December 31, 2021 | 41.33M |
| September 30, 2021 | 43.10M |
| June 30, 2021 | 39.93M |
| March 31, 2021 | 43.54M |
| December 31, 2020 | 34.62M |
| September 30, 2020 | 36.19M |
| Date | Value |
|---|---|
| June 30, 2020 | 37.13M |
| March 31, 2020 | 14.29M |
| December 31, 2019 | 11.11M |
| September 30, 2019 | 7.907M |
| June 30, 2019 | 7.307M |
| March 31, 2019 | 8.618M |
| December 31, 2018 | 9.247M |
| September 30, 2018 | 12.23M |
| June 30, 2018 | 14.33M |
| March 31, 2018 | 15.39M |
| December 31, 2017 | 16.27M |
| September 30, 2017 | 15.79M |
| June 30, 2017 | 14.22M |
| March 31, 2017 | 14.07M |
| December 31, 2016 | 18.75M |
| September 30, 2016 | 24.47M |
| June 30, 2016 | 13.89M |
| March 31, 2016 | 16.98M |
| December 31, 2015 | 16.07M |
| September 30, 2015 | 19.88M |
| June 30, 2015 | 23.69M |
| March 31, 2015 | 27.47M |
| December 31, 2014 | 13.63M |
| September 30, 2014 | 16.28M |
| June 30, 2014 | 18.44M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ARS Pharmaceuticals, Inc. | 251.48M |
| Alnylam Pharmaceuticals, Inc. | 7.995B |
| Regeneron Pharmaceuticals, Inc. | 44.41B |
| SELLAS Life Sciences Group, Inc. | 145.38M |
| Sionna Therapeutics, Inc. | 263.26M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 120.61M |
| Shareholders Equity (Quarterly) | 209.76M |
| Debt to Equity Ratio | 0.4397 |
| Current Ratio | 6.765 |
| Net Debt Paydown Yield | -3.19% |